Udai Pandey, PhD

  • Professor of Pediatrics
  • Director, Children's Neuroscience Institute

Udai Pandey, PhD, is a Professor in the Department of Pediatrics, Division of Pediatric Neurology at the Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center. Dr. Pandey earned his PhD in Medical Genetics from Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India. He did his postdoctoral training in Dr. J Paul Taylor’s laboratory in the Department of Neurology at the University of Pennsylvania Medical Center and St. Jude Children’s Research Hospital. Prior to relocating to Pittsburgh in 2014, Dr. Pandey was an Assistant Professor of Genetics at the Louisiana State University Health Sciences Center, New Orleans. The focus of Pandey laboratory is to elucidate the molecular mechanisms of adult and pediatric onset neurological diseases including amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, and other related motor neurons diseases. Recently, Dr. Pandey’s lab discovered novel pathogenic mutations in GEMIN5, an RNA-binding protein, among patients with developmental delay, ataxia, and motor dysfunction. Several RNA-binding proteins have been linked with different forms of human neurodegenerative diseases including ALS. Disease causing mutations in these RNA binding proteins suggest that underlying defects in RNA metabolism might play an important role in causing motor neuron degeneration. The Pandey lab developed cellular and animal models of neurodegenerative diseases that recapitulate several key pathological features of human disease such as neurodegeneration and behavioral defects. We are utilizing cell biological, genetic and biochemical techniques to understand molecular mechanisms of neurodegeneration in animal, induced pluripotent stem cells and patient postmortem tissues. The Pandey lab is looking for genetic and small molecule modifiers of neurological diseases using different models. Dr. Pandey has published more than 51 manuscripts in high-impact journals.

Invited Seminars and Lectureships

  • 09/2024, Invited Speaker, Motor Neuron Disease Research Center, Columbia University Medical Center, New York (Host: Dr. Anand Goswami)
  • 01/2025 Invited Speaker, 49th Annual Meeting of ISHG and International Conclave on Neurogenetics, NIMHANS, Bengaluru, India

Professional and Scientific Society Memberships

  • Society for Neuroscience, Member, 2007 - Present
  • Genetics Society of America, Member, 2012 - Present

 

Education & Training

  • MS, Dr. Ram Manohar Lohia Avadh University, 1999
  • PHD, Sanjay Gandhi Postgraduate Institute of Medical Sciences, 2003
  • Post Doctoral Fellowship, University of Pennsylvania Medical Center and St Jude Children’s Research Hospital, 2009

Selected Publications

Khan M, Chen XXL, Dias M, Santos JR, Kour S, You J, van Bruggen R, Youssef MMM, Wan YW, Liu Z, Rosenfeld JA, Tan Q, Pandey UB, Yalamanchili HK, Park J. MATR3 pathogenic variants differentially impair its cryptic splicing repression function. FEBS Lett. 2024 Feb 6. doi: 10.1002/1873-3468.14806. Epub ahead of print. PMID: 38320753 

Yadav S, Graham A, Al Hammood F, Garbark C, Vasudevan D, Pandey U, Asara JM, Rajasundaram D, Parkhitko AA. Unique tau- and synuclein-dependent metabolic reprogramming in neurons distinct from normal aging. Aging Cell. 2024 Aug 13:e14277. doi: 10.1111/acel.14277. Epub ahead of print. PMID: 39137949. 

Silvestri B, Mochi M, Mawrie D, Turris VD, Colantoni A, Borhy B, Medici M1, Anderson EN, Garone MG, Zammerilla CP, Simula M, Ballarino M, Pandey UB and Rosa A. HuD impairs neuromuscular junctions and induces apoptosis in human iPSC and Drosophila ALS models. Nat Commun. 2024 Nov 7;15(1):9618. doi: 10.1038/s41467-024-54004-8. 

View MyNCBI Bibliography » 

Academic and Research Interests

  • Neuroscience
  • Neurological diseases
  • Motor neuron disease
  • Neurodegeneration
  • Developmental disorders
  • Amyothrophic lateral sclerosis
  • Traumatic brain injury
  • Genetic disorders
  • Animal models

Research Grants

NINDS/NIA 1R01NS134166-01, Investigating the Contribution of  ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology, 07/01/2023 - 06/30/2028, MPI: Kiskinia/Pabdey

NINDS/NIH 1R01NS134215-01, Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome, 07/01/2023 - 06/30/2028, PI

NIA/NIH K99AG075363-01A1, Investigating the role of traumatic injury in amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD), 07/01/2022 - 06/30/2027, Mentor

NINDS/NIH 1R01NS104219-01A1, Genetic Analysis of UBQLN2-associated Neurodegeneration in Frontotemporal Dementia, 09/01/2020 – 08/31/2024, Co-Investigator (PI: Randel Tibbetts)

NINDS/NIH 1R01AG069483-01A1, Determining how defective nucleo-cytoplasmic trafficking leads to neurodegeneration in C9ORF72-related ALS and FTD, 03/01/2018 – 02/28/2023, Co-Investigator (PI: Evangelos Kiskinis)

NINDS/ NIH 2R01NS081303-01A1, Cellular and Molecular Mechanisms of FUS-related neurodegeneration, 04/15/2019 – 12/31/2024, PI

 

CV